Statins and renal cell carcinoma: Antitumor activity and influence on cancer risk and survival
Matteo Santoni, Fernando Sabino M Monteiro, Francesco Massari, Halima Abahssain, Gaetano Aurilio, Javier Molina-Cerrillo, Zin W Myint, Ignacio Ortego Zabalza, Nicola Battelli, Enrique Grande DOI: 10.1016/j.critrevonc.2022.103731 Full link: https://www.sciencedirect.com/science/article/abs/pii/S104084282200155X?via%3Dihub
Optimizing treatment selection and sequencing decisions for first-line maintenance therapy of newly diagnosed advanced ovarian cancer
Jeffrey C H Goh, Charlie Gourley, David S P Tan, Angélica Nogueira-Rodrigues, Hesham Elghazaly, Marc Edy Pierre, Gonzalo Giornelli, Byoung-Gie Kim, Flavia Morales-Vasquez, Alexandra Tyulyandina DOI: 10.1016/j.gore.2022.101028 Full link: https://www.sciencedirect.com/science/article/pii/S2352578922001084?via%3Dihub
Choosing Wisely for oncology in Brazil: 10 recommendations to deliver evidence-based cancer care
Fabio Ynoe de Moraes, Gustavo Nader Marta , Gunita Mitera, Daniel Neves Forte, Rodrigo Nascimento Pinheiro, Nivaldo F Vieira, Rafael Gadia, Maira Caleffi, Patricia Chiappin Kauer, Luciana Holtz de Camargo Barros, Clarissa Mathias, Karina Gondim Moutinho da Conceicao Vasconcelos, Christopher Booth, Gustavo Dos Santos Fernandes DOI: 10.1038/s41591-022-01924-x Full link: https://www.nature.com/articles/s41591-022-01924-x
The Lancet Summit: Cancer care in Asia and Latin America
We are pleased to announce that the Asian Oncology Summit, organised by The Lancet Oncology, is set to return in 2022 for the 9th time, and on this occasion will be held in conjunction with the 1st Latin American Oncology Summit. This renewed event aims to highlight clinical and global oncology topics relevant for both Asia and Latin America in a post-pandemic world, allowing attendees to share experiences and learnings in both settings, to foster interdisciplinary and multinational collaboration, and to help inspire ideas to restore and improve cancer care and control. Key opinion leaders from across Asia and Latin America will lead discussion on clinical and global oncology topics relevant for both regions in a post-pandemic world. Dr. Carlos Barrios and Dr. Gustavo Werutsky representing LACOG are among the speakers. For the first time, making use of a virtual format, this 2-day Summit is designed to enable the same topics to be discussed in multiple time zones and for each to share the lessons learned, creating a unique opportunity for researchers, clinicians, and policymakers to gain insights from other parts of the world to facilitate new opportunities and understanding of mutual benefit. Alongside the scientific sessions, this joint Summit will
Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study
Tomas Reinert, Susana Ramalho, Vivian CA Vasconcelos, Leonardo R Silva, Ana Elisa R Silva, Camila A Andrade, Maria Beatriz PL Kraft, Guilherme P Coelho, Jovana Mandelli, Monique Binotto, Cesar Cabello, Geisilene RP Silva, Jose Bines, Carlos H Barrios, Matthew J Ellis and Marcia S Graudenz.
Moderately hypofractionated radiation therapy for breast cancer: A Brazilian cohort study
Gabriela S.M. de Siqueira, Samir A. Hanna, Larissa F. de Moura, Fabiana Accioli Miranda, Heloísa de Andrade Carvalho, Gustavo Nader Marta DOI: https://doi.org/10.1016/j.lana.2022.100323 Full link: https://www.thelancet.com/journals/lanam/article/PIIS2667-193X(22)00140-5/fulltext
Implications of the PEARL trial from the low- to middle-income countries’ perspectives
Tomás Reinert, Aline C Gonçalves, C A A de Resende, Carlos H Barrios DOI: DOI: 10.1016/j.ejca.2022.06.016 Full link: https://linkinghub.elsevier.com/retrieve/pii/S0959804922003677
Barriers and facilitators to provide multidisciplinary care for breast cancer patients in five Latin American countries: A descriptive-interpretative qualitative study
Carlos Barrios, Guillermo Sánchez-Vanegas, Cynthia Villarreal-Garza, Andrés Ossa, Milton A Lombana, Angélica Monterrosa-Blanco, Ana S Ferrigno, Carlos Alberto Castro DOI: 10.1016/j.lana.2022.100254 Full link: https://pubmed.ncbi.nlm.nih.gov/36778924/
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772
Impact of COVID-19 on the curative treatment of prostate cancer: a national cross-sectional study
Andre G Gouveia, Fabio Y Moraes, Renato P Lima, Gustavo A Viani DOI: 10.5603/RPOR.a2022.0070 Full link: https://journals.viamedica.pl/rpor/article/view/90772